What's New  A Medicare Certified Lung Transplant Program
A Medicare Certified Lung Transplant Program
The NewYork-Presbyterian Lung Transplant Program at Columbia University Medical Center has received Medicare certification for lung transplantation.
Medicare covers eligible patients who enter our program for preoperative evaluation, lung transplant surgery and postoperative care.
In certifying the NYP Lung Transplant Program, Medicare recognizes the outstanding results achieved by Joshua R. Sonett, MD, Surgical Director, and Selim M. Arcasoy, MD, Medical Director, and their team:
Lung transplants performed during July 1, 2001 -November 30, 2006 at NewYork-Presbyterian/Columbia have a one-year survival rate of 92% and four-year survival rate of 73%.
The operative and 30-day survival rate is 98%.
These excellent outcomes, which far exceed average national outcomes, are especially significant because of the Program's high-risk patient base.
hese results reflect the dedication of the Lung Transplant Program's experienced multidisciplinary team, and the comprehensive support of the Columbia Weill Cornell faculty and staff, whose first priority is quality of care.
Transplantation is one of several therapeutic options for advanced lung disease that is offered through the NewYork-Presbyterian Lung Transplant Program; others include
- Management of co-morbidities of advanced lung disease
- Lung volume reduction surgery (LVRS) for emphysema
- Advanced minimally invasive and robotic techniques for lung and diaphragmatic surgery
- Recommendations for novel therapy regimens directly through our program or others, such as Cystic Fibrosis Center, Pulmonary Fibrosis, and Pulmonary Hypertension Programs
For further information about the NewYork-Presbyterian Lung Transplant Program, please call 201.346.7001, or 1.212.305.7771.
|
